Related Experiment Video
Updated: Jun 29, 2025
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.0K
Clostridioides difficile infection: a changing treatment paradigm.
Yousif Al Naser1, Marriam AlGashami2, Layth Aljashaami3
1McMaster University, Hamilton, ON, Canada.
Przeglad Gastroenterologiczny
|April 4, 2024
Summary
Clostridioides difficile infection (CDI) management is evolving, with new drugs and microbiome therapies offering improved treatment options. Current strategies balance efficacy, cost, and safety for better patient outcomes in CDI care.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Clostridioides difficile infection (CDI) presents significant healthcare challenges, causing substantial morbidity and mortality.
- Current management relies on established guidelines from organizations like IDSA, SHEA, and ESCMID.
- The need for effective and safe CDI treatments remains a critical public health concern.
Purpose of the Study:
- To review current Clostridioides difficile infection management strategies.
- To highlight recent advancements in drug development for CDI treatment.
- To discuss the evolving landscape of CDI therapeutics, including microbiome restoration.
Main Methods:
- Comprehensive literature review of current Clostridioides difficile infection (CDI) management.
- Analysis of guidelines from IDSA, SHEA, and ESCMID.
- Evaluation of emerging therapies and their potential impact on CDI treatment paradigms.
Main Results:
- Current treatments include fidaxomicin, vancomycin, bezlotoxumab, and fecal microbiota transplantation, each with distinct advantages and limitations.
- Fidaxomicin shows efficacy but faces resource constraints; vancomycin is a practical alternative.
- Bezlotoxumab and fecal microbiota transplantation offer adjunct and highly effective options, respectively, but have associated cost, safety, and evolving considerations.
- Promising novel therapies like SER-109 and Rebyota are on the horizon.
Conclusions:
- The management of Clostridioides difficile infection is advancing with new therapeutic options.
- Standardized microbiome restoration therapies are crucial for long-term safety and treatment diversification.
- The evolving treatment landscape aims to improve efficacy, safety, and accessibility for CDI patients.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
3.6K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.6K
01:30Cleaning, Sterilization, and Disinfection
6.7K
Cleaning, disinfection, and sterilization are the methods that help to break the infection chain and prevent disease.
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
6.7K